Survival Differences Among Patients (pts) with Acute Myeloid Leukemia (AML) Treated with Allogeneic Hematopoietic Cell Transplantation (HCT) Versus Non-HCT Therapies: A Large Real-Time Multi-Center Prospective Longitudinal Observational Study


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Sorror, ML; Storer, BE; Gerds, AT; Medeiros, BC; Shami, PJ; Galvin, JP; Adekola, KU; Luger, S; Baer, MR; Rizzieri, DA; Wildes, TM; Wang, ES; Faderl, S; Koprivnikar, JL; Sekeres, MA; Mukherjee, S; Smith, J; Garrison, M; Kojouri, K; Nyland, JE; Moore, RR; Fleuret, SL; Lynch, Y; Becker, PS; Percival, M-EM; Sandmaier, BM; Appelbaum, FR; Estey, EH

Published Date

  • November 29, 2018

Published In

Volume / Issue

  • 132 /

Published By


  • 5

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

International Standard Serial Number (ISSN)

  • 0006-4971

Digital Object Identifier (DOI)

  • 10.1182/blood-2018-99-113094

Conference Name

  • 60th Annual Meeting of the American-Society-of-Hematology (ASH)

Conference Location

  • San Diego, CA

Conference Start Date

  • December 1, 2018

Conference End Date

  • December 4, 2018